ARIMOCLOMOLFORMULIERUNG

European patent · EP3193840 · In force

Register entry

Publication number
EP3193840
Application number
EP15775371
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 15, 2015
Published
Jul 26, 2017
Granted
May 19, 2021
Protection ends at the latest
Sep 14, 2035
Next annual fee due
Sep 30, 2027
IPC classes
A61K 9/16 (2006.01)
A61K 31/4545 (2006.01)
A61K 9/50 (2006.01)
A61P 3/00 (2006.01)
A61P 3/10 (2006.01)
A61P 9/12 (2006.01)
A61P 13/12 (2006.01)
A61P 43/00 (2006.01)
Priority
DK 201470566 15.09.2014
PCT application
PCT/DK2015/050275 15.09.2015
PCT publication
WO2016/041561 24.03.2016
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Oct 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. Aug 19, 2025

    Agent’s address changed

    Representative
    Stolmár & Partner Intellectual Property S.à.r.l., Bahnhofstrasse 106, 8001 Zürich → Stolmár & Partner Intellectual Property GmbH, Bahnhofstrasse 11, 6210 Sursee

    Published in Swissreg on 19.08.2025

  4. Oct 3, 2024

    Change

    Published in Swissreg on 03.10.2024

  5. Feb 16, 2024

    Address changed

    Owner
    KemPharm Denmark A/S, Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark → Zevra Denmark A/S, Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark

    Published in Swissreg on 16.02.2024

  6. Oct 1, 2023

    Change

    Published in Swissreg on 01.10.2023

  7. Sep 21, 2023

    Transferred

    Owner
    KemPharm, Inc., 1180 Celebration Blvd., Suite 103, Celebration, FL 34747, USA → KemPharm Denmark A/S, Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark

    Published in Swissreg on 21.09.2023

  8. Aug 18, 2023

    Transferred

    Owner
    Orphazyme A/S, c/o COBIS A/S, Ole Maaløes Vej 3, 2200 Copenhagen N, Denmark → KemPharm, Inc., 1180 Celebration Blvd., Suite 103, Celebration, FL 34747, USA

    Published in Swissreg on 18.08.2023

5 earlier entries
  1. Nov 9, 2022

    Address changed

    Representative
    Stolmár & Partner Intellectual Property S.à.r.l, Rue du Cendrier 15, CP 1489, 1201 Genève → Stolmár & Partner Intellectual Property S.à.r.l., Bahnhofstrasse 106, 8001 Zürich

    Published in Swissreg on 09.11.2022

  2. Oct 1, 2022

    Change

    Published in Swissreg on 01.10.2022

  3. Mar 30, 2022

    Change

    Published in Swissreg on 30.03.2022

  4. Jul 16, 2021

    Agent entered

    Representative
    Stolmár & Partner Intellectual Property S.à.r.l, Rue du Cendrier 15, CP 1489, 1201 Genève

    Published in Swissreg on 16.07.2021

  5. May 19, 2021

    Granted

    Published in Swissreg on 19.05.2021

Parties

Holder

Zevra Denmark A/S

Ole Maaløes Vej 3, 2200 Copenhagen N, DK

Agent

Stolmár & Partner Intellectual Property GmbH

Bahnhofstrasse 11, 6210 Sursee

Inventor

JENSEN, Thomas Kirkegaard

2610 Rødovre, DK

CAMOZZI, Carlos Roberto

4052 Basel

BOLWIG, Gert Mads

2920 Charlottenlund, DK

HINSBY, Anders Mørkeberg

2900 Hellerup, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.